Elżbieta S.
- Country
- Poland
- Department
- Oddział Kardiologii i Reumatologii dla Dzieci
Research Overview
- Evaluation of Long-Term Safety and Efficacy of Baricitinib in Pediatric Patients with Juvenile Idiopathic Arthritis: A Phase 3 Multicenter Study
- Efficacy, Safety, and Pharmacokinetics of Subcutaneous Risankizumab Versus Adalimumab in Pediatric Patients with Active Juvenile Psoriatic Arthritis
- Efficacy, Safety, and Pharmacokinetics of Apremilast in Pediatric Patients with Active Juvenile Psoriatic Arthritis: A Phase 3, Multicenter, Double-Blind, Randomized Study
Data & Insights
Has run more than one trial at 36 of 77 partner sites.
Specializations
Paediatric and Adult Rheumatology
Clinical research activity in rheumatology spans inflammatory and autoimmune diseases, with emphasis on juvenile idiopathic arthritis, juvenile psoriatic arthritis, and systemic lupus erythematosus.
- Juvenile Idiopathic Arthritis
- Juvenile Psoriatic Arthritis
- Systemic Lupus Erythematosus
- Moderate to Severe Active Lupus
Interest also extends to targeted treatment options for pediatric autoimmune disease and refractory lupus nephritis.
Glomerular and Lupus-Related Kidney Disease
The investigator is involved in studies focused on immune-mediated renal disorders, particularly IgA nephropathy, primary membranous nephropathy, and lupus nephritis.
- IgA Nephropathy
- Primary Membranous Nephropathy
- Lupus Nephritis
- Chronic Kidney Disease
Additional therapeutic interest includes proteinuria reduction, preservation of kidney function, and management of chronic kidney disease-associated pruritus.
Inflammatory Bowel Disease
Research involvement includes ulcerative colitis and Crohn's disease, with attention to both pediatric and broader immune-mediated gastrointestinal care.
- Ulcerative Colitis
- Crohn's Disease
- Moderately to Severely Active Ulcerative Colitis
- Moderately to Severely Active Crohn's Disease
Therapeutic interests also include vedolizumab, ozanimod, and dual biological therapy for disease control.
Pediatric Bone and Growth Disorders
The clinical portfolio includes studies in osteogenesis imperfecta and other skeletal fragility conditions in children and adolescents.
- Osteogenesis Imperfecta
- Fracture Risk
- Bone Mineral Density
- Pediatric Skeletal Disorders
This area also connects with therapies aimed at improving bone strength and reducing clinical fractures.
Metabolic and Cardiovascular Comorbidity
Investigational work also covers obesity, type 2 diabetes mellitus, and cardiovascular disease, reflecting interest in chronic comorbidity management.
- Obesity
- Type 2 Diabetes Mellitus
- Heart Failure
- Atrial Fibrillation
Related therapeutic themes include thromboembolic prevention, heart failure care, and cardiometabolic risk reduction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.